Koers Shanghai Shyndec Pharmaceutical Co., Ltd.
Aandelen
600420
CNE000001JG2
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
10,68 CNY | +2,69% | +6,37% | +9,09% |
Omzet 2024 * | 13,35 mld. 1,84 mld. 1,72 mld. | Omzet 2025 * | 14,69 mld. 2,03 mld. 1,89 mld. | Marktkapitalisatie | 14,32 mld. 1,98 mld. 1,84 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 863 mln. 119 mln. 111 mln. | Nettowinst (verlies) 2025 * | 996 mln. 137 mln. 128 mln. | EV/omzet 2024 * | 1,07 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 0,98 x |
K/w-verhouding 2024 * |
16,7
x | K/w-verhouding 2025 * |
14,4
x | Werknemers | 11.608 |
Dividendrendement 2024 * |
14% | Dividendrendement 2025 * |
16,9% | Vrij verhandelbaar | 39,64% |
1 dag | +2,69% | ||
1 week | +6,37% | ||
Lopende maand | +19,46% | ||
1 maand | +22,34% | ||
3 maanden | +14,59% | ||
6 maanden | +10,67% | ||
Lopend jaar | +9,09% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wan Yong Lian
PSD | President | 54 | 24-09-22 |
Hao Li
DFI | Director of Finance/CFO | 59 | 18-11-16 |
Qian Yin Jing
IRC | Investor Relations Contact | 44 | 13-09-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yong Gang Xing
CHM | Chairman | 48 | 25-11-19 |
Yong Liu
BRD | Director/Board Member | 55 | 17-05-21 |
Shu Yuan Wei
BRD | Director/Board Member | 60 | 29-05-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +2,22% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 10,68 | +2,69% | 32 644 090 |
24-04-24 | 10,4 | +0,39% | 26 739 850 |
23-04-24 | 10,36 | -1,52% | 24 845 240 |
22-04-24 | 10,52 | +0,29% | 33 565 740 |
19-04-24 | 10,49 | +4,48% | 43 907 290 |
slotkoers Shanghai S.E., 25 april 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,09% | 1,98 mld. | |
+4,16% | 69,91 mld. | |
+11,20% | 9,03 mld. | |
-17,03% | 4,75 mld. | |
+37,51% | 4,31 mld. | |
+3,92% | 3,88 mld. | |
+18,14% | 2,37 mld. | |
-24,13% | 2,26 mld. | |
-29,70% | 2,2 mld. | |
+1,28% | 1,6 mld. |